Quantitative Evaluation of the Outcomes of Revascularization Procedures for Peripheral Arterial Disease Using Indocyanine Green Angiography  by Igari, K. et al.
Quantitative Evaluation of the Outcomes of Revascularization Procedures
for Peripheral Arterial Disease Using Indocyanine Green Angiography
K. Igari *, T. Kudo, T. Toyofuku, M. Jibiki, Y. Inoue, T. Kawano
Department of Esophageal and General Surgery, Tokyo Medical and Dental University Graduate School, Tokyo, Japan* Cor
8519, J
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
Indocyanine green angiography (ICGA), has been used in various clinical areas, such as plastic surgery, coronary
arterial disease, and peripheral arterial disease. Even though ICGA is useful for assessing tissue perfusion, the
quantitative parameters and cutoff level concerning with traditional clinical tests have not been deﬁned. Our
clinical data show the quantitative parameters for tissue perfusion with ICGA and ﬁrst deﬁnition of cutoff level
of tissue viability.Objectives: We performed indocyanine green angiography (ICGA) in patients with peripheral arterial disease
(PAD), and established a method for the quantitative measurement of appropriate parameters to assess
peripheral perfusion and the applicability of ICGA tests.
Methods: Twenty-one patients with PAD underwent revascularization procedures with pre- and
postinterventional ICGA tests. The ICGA parameters, which included the magnitude of intensity of indocyanine
green, the time to maximum intensity, and the time from ﬂuorescence onset to half the maximum intensity (T1/2)
were compared with the ankle-brachial pressure index, toe -brachial pressure index, and toe pressure. We
evaluated these parameters for regions of interest (ROIs).
Results: T1/2 was the strongest parameter among all parameters of the ICGA tests. ROI 3, which included the
distal region of the ﬁrst metatarsal bone, correlated more signiﬁcantly with the traditional measurements than
the other ROIs. A value of T1/2 >20 seconds for ROI 3 was signiﬁcantly correlated with a toe pressure of
<50 mmHg (sensitivity: 0.77, speciﬁcity: 0.80).
Conclusions: ICGA can be used to assess peripheral tissue perfusion. By measuring the value of T1/2 in ROI 3,
ICGA tests can be used to evaluate the outcomes of revascularization procedures.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Peripheral arterial diseaseINTRODUCTION
The introduction of noninvasive vascular laboratory tests
arose from the need to obtain more accurate differential
diagnoses, assessments of disease localization, and mea-
surements of severity in addition to documenting the pro-
gression of peripheral arterial disease (PAD) and the effects
of treatment. Several measurements can be used to assess
the severity of ischemia, such as the ankle-brachial pressure
index (ABI), absolute toe systolic pressure (TP), toe-brachial
pressure index (TBI), and transcutaneous oxygen tension
(tcPO2). However, clinical tests measuring limb perfusion
and hemodynamics are often limited by a variety of issues,
including the presence of open and/or infected wounds,responding author. K. Igari, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-
apan.
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//dx.doi.org/10.1016/j.ejvs.2013.07.016previous toe or forefoot amputation, and media sclerosis
causing false elevation of the systolic pressure.1
Indocyanine green (ICG) has been clinically used as a type
of near infrared (NIR) ﬂuorophore for intravital imaging, a
marker of the liver function,2 and a sensitizer for photo-
dynamic therapy.3,4 ICG angiography (ICGA) has the po-
tential to provide information about regional perfusion and
has recently been used to assess the viability of ﬂap
perfusion.5e7 Previous reports have demonstrated its use in
the subjective assessment of tissue perfusion in patients
with PAD.8,9 ICGA can provide excellent and informative
images of tissue perfusion; however, it offers little quanti-
tative information.10 Furthermore, even though the quan-
titative data may change according to the settings of the
region of interest (ROI), in which parameters of the ﬂuo-
rescence intensity and time are evaluated, there have been
no reports referring to the establishment of an ideal ROI.
The aim of this study was to establish a protocol for ICGA
and to develop quantitative parameters of peripheral tissue
perfusion, including the settings of ROIs. Furthermore, we
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traditional clinical tests, including ABI measurement.
METHODS
Patients
All protocols, surveys, and consent forms were approved by
the Institutional Review Board of Tokyo Medical and Dental
University Hospital. Written informed consent was obtained
from all patients. Between November 2012 and February
2013, 36 patients underwent 43 revascularization pro-
cedures for PAD. Because ICG contains sodium iodide, we
did not perform ICGA tests in patients with previous allergic
reactions to iodinated contrast agents. Patients without
both pre- and postintervention ICGA tests were also
excluded from this study. We performed both pre- and
postintervention ICGA tests in a total of 23 limbs in 21
patients. According to the Rutherford classiﬁcation,11 there
was one limb in category 2, 17 limbs in category 3, and ﬁve
limbs in category 4.
ICGA tests
The ICGA test protocol is shown in Table 1. A 0.1-mg/kg
dose of ICG (Diagnogreen; Daiichi-Sankyo Pharmatical,
Tokyo, Japan) was intravenously injected via a peripheral
venous line. Immediately after the injection of ICG, ﬂuo-
rescence images were obtained using an infrared camera
system (Photodynamic Eye, Hamamatsu Photonics K.K.,
Hamamatsu, Japan), which activated the ICG with emitted
light at a wavelength of 760 nm and ﬁltered out light with a
wavelength of <820 nm. The light source for the emission
of ICG consisted of 760 nm light-emitting diodes, and the
detector was a charge-coupled device camera. Real-time
ﬂuorescence images were displayed on a monitor and
recorded using a digital image processing method of theTable 1. Indocyanine green (ICG) angiography protocol.
 Clear the patient of contraindications
 Supine positioned of patients
 Position the camera over the foot at
20 cm from the skin
 Remove any dressings and extinguish
overhead lights
 A 0.1 mg/kg of 0.1% ICG solution
administrated intravenously with bolus
infusion, and push 10 mL normal saline
to ﬂush intravenous route
 After the injection, start capturing and
recording for 5 minAudio Video Interweave system. ICG is nontoxic and has a
very low incidence of adverse reactions (1/40,000 doses).12
Pre-interventional ICGA tests were performed before the
interventional procedures, and postinterventional ICGA
tests were performed within 7 days of the interventional
procedures (Fig. 1A and B).ICGA image analysis
For the comparative measurements, we set three types of
ROIs: (1) from the Chopart joint (the tarsal joint that com-
prises the talonavicular and calcaneocuboid articulations) to
the Lisfranc joint (the articulation between the tarsal and
metatarsal bones); (2) at the metatarsal bones; and (3) in
the distal region of the ﬁrst metatarsal bone (Fig. 2). In
order to evaluate the ICGA tests, multiple parameters were
obtained and analyzed to assess perfusion. These parame-
ters included the magnitude of intensity from ICG onset to
maximum intensity (Imax), the time from ICG onset to
maximum intensity (Tmax), the slope of the intensity in-
crease from ICG onset to maximum intensity (S), the time
elapsed from the ﬂuorescence onset to half the maximum
intensity (T1/2), and the ﬂuorescence intensity measured 10
seconds after the onset of ﬂuorescence (PDE10) (Fig. 3).
Image processing and data analysis were performed using
the ROIs version U11437 software program (Hamamatsu
Photonics K.K., Hamamatsu, Japan).
The obtained parameters were also compared with
traditional measurements, including the ABI, TBI, and TP,
measured using the VasoGuard P84 system (SciMed Ltd,
Bristol, UK). In all cases, hemodynamic parameters, such as
the pulse rate and blood pressure, were within the normal
ranges. In this study, clinical success was deﬁned as a moreFigure 1. A diagram of the imaging system. (A) Capturing the
indocyanine green imaging. (B) The system contains the imaging
system, which has a charge-coupled device (CCD) camera (white
arrow) with near-infrared light-emitting diode arrays, and a com-
puter system for the image analysis (black arrow).
Figure 2. The settings of the regions of interest (ROI). ROI 1: from
the Chopart joint to the Lisfranc joint; ROI 2: at the metatarsal
bones; ROI 3: at the distal region of the ﬁrst metatarsal bone.
Table 2. Ankle-brachial pressure index (ABI), toe-brachial pressure
index (TBI), absolute toe systolic pressure (TP), and indocyanine
green angiography (ICGA) parameters values pre- and
postintervention.
Pre-intervention Postintervention p
ABI 0.632  0.283 0.959  0.215 <.0001
TBI 0.354  0.185 0.642  0.206 <.0001
TP 49.8  26.0 85.9  25.6 <.0001
ROI 1
Imax 26.6  10.6 43.2  12.8 <.0001
Tmax 99.5  31.1 68.1  29.4 .001
S 0.293  0.149 0.792  0.476 <.0001
T1/2 34.0  10.5 23.7  11.7 .0005
PDE10 1.43  1.53 6.07  5.05 .0001
ROI 2
Imax 23.7  11.4 42.9  14.1 <.0001
Tmax 89.3  39.1 53.0  26.5 .0011
S 0.325  0.210 1.08  0.724 <.0001
T1/2 31.4  13.1 18.3  7.42 .0001
PDE10 1.98  2.27 10.1  8.91 .0001
ROI 3
Imax 23.3  12.3 45.5  17.2 <.0001
Tmax 85.1  57.5 47.5  27.7 .0048
S 0.404  0.300 1.37  1.02 <.0001
T1/2 31.4  17.5 15.1  7.07 .0001
PDE10 3.42  3.48 15.9  11.7 <.0001
Note. Other ICGA parameters were seen in the “Methods” section.
ROI ¼ region of interest; Imax ¼ magnitude of intensity from ICG
onset to maximum intensity; Tmax ¼ time from ICG onset to
maximum intensity; S ¼ slope of intensity increase from ICG
onset to maximum intensity; T1/2 ¼ time elapsed from
462 K. Igari et al.than 0.1 increase in the ABI following the revascularization
procedures, with an upward shift of at least one Rutherford
clinical category, except in patients with actual tissue loss
(categories 5 and 6), who were required to move up at least
two categories.11ﬂuorescence onset to half the maximum intensity;
PDE10 ¼ ﬂuorescence intensity measured 10 seconds after the
onset of ﬂuorescence.Statistical analysis
The data are expressed as the mean  SD. Statistical sig-
niﬁcance was assessed using the ManneWhitney U test for
continuous variables, and Spearman’s rank correlation co-
efﬁcients were used to reﬂect the degree of relationshipsFigure 3. Indocyanine green angiography test parameters were
deﬁned graphically. (A) Imax; (B); Tmax; (C) S ¼ Imax/Tmax; (D) T1/2;
(E) PDE10. Note. Imax ¼ magnitude of intensity from ICG onset to
maximum intensity; Tmax ¼ time from ICG onset to maximum in-
tensity; S ¼ slope of intensity increase from ICG onset to
maximum intensity; T1/2 ¼ time elapsed from ﬂuorescence onset
to half the maximum intensity; PDE10 ¼ ﬂuorescence intensity
measured 10 seconds after the onset of ﬂuorescence.between variables. Statistical analyses were performed us-
ing Stat View v. 5 (Abacus Concept, Berkley, CA, USA).
RESULTS
Patient characteristics
During the study period, 21 patients underwent 23 revas-
cularization procedures, and both pre- and postinterven-
tional ICGA tests. We performed three open surgeries: two
cases of thromboendarterectomy at the common femoral
artery and one case of femoropopliteal bypass surgery.
Eighteen of the 23 revascularization procedures were
endovascular procedures: 10 aortoiliac lesions, nine femoral
and popliteal lesions, and two infrapopliteal tibioperoneal
lesions. Two procedures were hybrid procedures, including
simultaneous open surgery and endovascular treatment.
One procedure was simultaneous thromboendarterectomy
at the common femoral artery and endovascular treatment
of aortoiliac stenotic lesions, and the other was simulta-
neous femoropopliteal bypass surgery and endovascular
treatment of aortoiliac stenotic lesions. The average age of
the patients was 72.7 years (range: 59e88 years) and 17
patients were men. The documented comorbidities were
hypertension (76%), dyslipidemia (57%), diabetes mellitus
Table 3. Correlation of ankle-brachial pressure index (ABI), toe-brachial pressure index (TBI), and absolute toe systolic pressure (TP) with
indocyanine green angiography (ICGA) parameters on regions of interest (ROI) 1, 2, and 3.
ABI r (Spearman) p TBI r (Spearman) p TP r (Spearman) p
Variable
ROI 1
Imax 0.288 .0530 0.424 .0045 0.373 .0122
Tmax 0.330 .0268 0.475 .0014 0.427 .0041
S 0.366 .0140 0.522 .0005 0.462 .0020
T1/2 0.437 .0034 0.495 .0009 0.494 .0009
PDE10 0.442 .0030 0.529 .0004 0.508 .0007
ROI 2
Imax 0.358 .0163 0.486 .0011 0.462 .0019
Tmax 0.439 .0032 0.546 .0003 0.495 .0009
S 0.491 .0010 0.599 <.0001 0.551 .0002
T1/2 0.489 .0010 0.577 .0001 0.563 .0002
PDE10 0.413 .0056 0.537 .0003 0.535 .0003
ROI 3
Imax 0.469 .0016 0.469 .0016 0.482 .0012
Tmax 0.360 .0158 0.549 .0002 0.580 .0001
S 0.513 .0006 0.590 <.0001 0.621 <.0001
T1/2 0.530 .0004 0.614 <.0001 0.627 <.0001
PDE10 0.520 .0005 0.581 <.0001 0.616 <.0001
Note. Other ICGA parameters were seen in the “Methods” section. ROI ¼ region of interest; Imax ¼ magnitude of intensity from ICG onset
to maximum intensity; Tmax ¼ time from ICG onset to maximum intensity; S ¼ slope of intensity increase from ICG onset to maximum
intensity; T1/2 ¼ time elapsed from ﬂuorescence onset to half the maximum intensity; PDE10 ¼ ﬂuorescence intensity measured 10
seconds after the onset of ﬂuorescence.
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nary artery disease (23%), and chronic kidney disease
requiring hemodialysis (10%). All procedures resulted in
improvement of the ABI postoperatively; however, clinical
success was achieved in only 19 limbs (82%).Evaluation of the revascularization procedures using ICGA
tests
In this study, all procedures were evaluated based on the
results of pre- and postinterventional ICGA tests. With
respect to the measurements of ROI 1, 2, and 3, the values
of Imax, Tmax, S, T1/2, and PDE10 were all signiﬁcantly different
between the pre- and postinterventional ICGA tests. We
also evaluated the interventional outcomes using the
traditional measurements of ABI, TBI, and TP, all of which
exhibited statistically signiﬁcant improvement from the pre-
interventional measurements to the postinterventional
measurements (Table 2).
We compared the ICGA test parameters and traditional
parameters measured with the ABI, TBI, and TP. The ABI
exhibited a statistically signiﬁcant correlationwith the Tmax, S,
T1/2, and PDE10 in ROI 1, while the Imax,Tmax, S,T1/2, and PDE10
demonstrated signiﬁcant correlations with each other in ROI
2, and the Imax, Tmax, S, T1/2 and PDE10 showed signiﬁcant
correlations with each other in ROI 3. The TBI exhibited a
statistically signiﬁcant correlation with the Imax, Tmax, S, T1/2
and PDE10 in all three ROIs. The TP also showed a statistically
signiﬁcant correlation with the Imax, Tmax, S, T1/2 and PDE10 in
all ROIs (Table 3).Evaluation of the ROIs
The T1/2 of ROI 3 demonstrated the most statistically sig-
niﬁcant correlation with the TP; this was the strongest
correlation observed for any parameter in any ROI. After
setting the value of the T1/2 in ROI 3 as a cutoff (20 sec-
onds), the ICGA test predicted that 50 mmHg was the
borderline value for TP, with a sensitivity of 0.77, a speci-
ﬁcity of 0.80, and an area under the receiver operating
characteristic curve of 0.862 (Fig. 4).DISCUSSION
Perfusion imaging tools used to visualize the structure of
the vasculature or obtain functional perfusion information
are useful and have several clinical applications. Although
computed tomography angiography is widely used, it pro-
vides only structural information, not functional informa-
tion, about the blood ﬂow. Because the prognosis of
vascular insufﬁciency is directly coupled with the functional
perfusion level, rather than the vascular structure,13 func-
tional perfusion imaging is superior to structural vascular
imaging.
ICGA has been a focus of research owing to its convenience
and effectiveness for imaging the vasculature and allowing
for estimation of tissue perfusion.10 Previous studies that
have used ICGA tests to estimate blood perfusion failed to
provide the quantitative information required for interindi-
vidual comparisons,14 and ICGA has been primarily applied
for ﬂow assessment.15,16 In this article, we demonstrated
that ICGA tests are useful for the quantitative measurement
Figure 4. The receiver operating characteristic curve of the value of
T1/2 for region of interest 3 for an absolute toe systolic pressure
value of 50 mmHg, with a sensitivity of 0.77, a speciﬁcity of 0.80,
and an area under the curve of 0.86. Note. T1/2 ¼ time elapsed
from ﬂuorescence onset to half the maximum intensity.
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ICGA tests can be quickly and reliably derived from the im-
ages to determine the degree of tissue perfusion and eval-
uate the therapeutic effects of revascularization procedures.
Kang et al.17 reported encouraging preliminary data using the
time to maximum intensity as an indicator in patients with
Raynaud’s phenomenon. Braun et al.18 reported that both
ﬂuorescence intensity and time parameters are signiﬁcantly
correlated with the outcomes of revascularization pro-
cedures and can be used as novel parameters. However, the
intensity of ICG depends on the distance from the camera to
the skin, the patient’s skin color, and the ambient light in the
testing room, as reported in a prior study.18 Therefore, we
believe that the intensity of ICG is not a good parameter for
assessing tissue perfusion using ICGA tests. In the present
study, although the parameters related to the intensity of
ICG, including the Imax, S, and PDE10, were correlated with the
ABI, TBI, and TP, the Tmax and T1/2 were more signiﬁcantly
correlated than the other parameters. Parameters inﬂuenced
based on the time after ICG injection may be the best pa-
rameters. Furthermore, until recently, there have been no
reports concerning the settings of ROIs. We therefore eval-
uated the accuracy of different settings of ROIs and found
that ROI 3 was most highly correlated with the ICGA pa-
rameters. With respect to ROI 3, the ICGA tests primarily
measured the perfusion of the toe arteries; therefore, the TBI
and TP correlated more signiﬁcantly with the parameters
than did the ABI. Furthermore, we deﬁned the value of T1/2
on ROI 3 as the cutoff value and evaluated the accuracy of the
borderline (50 mmHg) TP value. The Trans-Atlantic Inter-So-
ciety Consensus19 requires a ﬁnding of a TP of<50 mmHg in
order to conﬁrm a diagnosis of critical limb ischemia (CLI),
and a T1/2 of >20 seconds may also predict the presence of
CLI. We believe that the present study is the ﬁrst attempt to
propose quantitative parameters, suitable settings for ROIs,
and a cutoff value of CLI for ICGA tests.
Furthermore, ICGA tests are useful as minimally invasive
tools for determining the tissue viability in patients who
lack toe pulses due to ulceration or amputation of the toes,and patients with an abnormal ABI due to medial calciﬁ-
cation. Further studies of ICGA testing should be performed
to assess its ability to predict the optimal treatment for
PAD, including the need for revascularization procedures,
and to evaluate the outcomes of revascularization pro-
cedures intra-operatively. This may help to determine
whether further procedures are needed to improve tissue
perfusion and wound healing.
There are several limitations to this study, the foremost
being the small sample size. Although only a small number
of patients were enrolled, our study demonstrated that
ICGA tests provide highly reliable and quantitative esti-
mates of peripheral tissue perfusion. There are additional
variables that may affect the speciﬁcity of ICGA tests,
including the presence of open wounds and inﬂammation,
which can change the tissue perfusion, resulting in over-
estimation of the degree of actual perfusion. Although
these limitations will need to be examined in future studies,
the advantages of ICGA tests could help in selecting treat-
ments for PAD.
In conclusion, our results indicate that ICGA tests rapidly
provide qualitative and visual information regarding the
regional perfusion of the foot, and can be used to quanti-
tatively evaluate the degree of perfusion in peripheral tis-
sues. Moreover, ICGA tests can be used to predict wound
healing. A value of T1/2 in ROI 3 of >20 seconds predicts a
TP of <50 mmHg. Although further studies are needed to
evaluate the reliability of these parameters, especially in
deﬁning and grading the severity of PAD, we believe that
our results obtained using the quantitative analysis of ICGA
tests will contribute to the development of new clinical
diagnostic tools for assessing PAD.CONFLICT OF INTEREST
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